Common Equity: The sum of all common equity items.
Lantern Pharma Inc. (LTRN) had Common Equity of $40.91M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-15.96M |
|
-- |
|
-- |
|
$17.88M |
|
$-17.88M |
|
$1.92M |
|
$-15.96M |
|
$-15.96M |
|
$-15.96M |
|
$-15.96M |
|
$-15.96M |
|
$-15.96M |
|
$-17.88M |
|
$-18.04M |
|
10.84M |
|
10.84M |
|
$-1.47 |
|
$-1.47 |
|
Balance Sheet Financials | |
$43.34M |
|
$0.05M |
|
$0.31M |
|
$43.65M |
|
$2.68M |
|
-- |
|
$0.06M |
|
$2.74M |
|
Common Equity |
$40.91M |
$40.91M |
|
$40.91M |
|
10.72M |
|
Cash Flow Statement Financials | |
$-14.35M |
|
$-0.93M |
|
$-0.50M |
|
$37.74M |
|
$21.94M |
|
$-15.81M |
|
$1.07M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
16.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-39.02% |
|
-39.02% |
|
-36.57% |
|
-39.02% |
|
$3.82 |
|
$-1.32 |
|
$-1.32 |